News
May 12, 2014
Human heart beats using nearly billion-year-old molecular mechanism
Neurobiologist Tim Jegla and his Lab find in a living, ancient sea anemone species the same gene family and ion channel that regulate the slow wave contractions of the human heart.
Full Article
Apr 14, 2014
Existence of new neuron repair pathway discovered
The Rolls Lab discovers a new neuron repair pathway that could one day help people suffering from nerve damage.
Full Article
Jan 21, 2014
Announcing major equipment acquisitions at the Huck Institutes
The Huck Institutes of the Life Sciences, in conjunction with the Office of the Vice President for Research and the Office of the Provost, are pleased to announce several major equipment acquisitions that will further strengthen the research capabilities of their Core Facilities at University Park.
Full Article
Dec 09, 2013
Digital PCR Now Available
The Genomics Core Facility has acquired the QuantStudio 3D Digital PCR System.
Full Article
Sep 04, 2012
New Illumina DNA sequencers acquired by the Genomics Core Facility
A HiSeq 2000 has been obtained through a grant from the National Science Foundation's Major Research Instrumentation Program, and a MiSeq has been purchased with funding from the Huck Institutes.
Full Article
Apr 22, 2012
Life Technologies' Ion Bus comes to Penn State
On its way from Pittsburgh to Philadelphia, the Bus makes a stop in Happy Valley to showcase its genome sequencing technology.
Full Article
Aug 25, 2011
Huck Institutes to host 2nd Annual Bioinformatics and Genomics Retreat - September 16th & 17th, 2011
Keynote speaker Dr. Richard Edward Green. Visionary talk and panel discussion. Poster sessions. Research presentations. Open to all Penn State faculty, postdocs, students, and staff. Registration is free!
Full Article
Aug 03, 2010
Ancient gene family linked to the future of epileptic seizures
A potassium-channel gene belonging to an ancient gene family more than 542 million years old is opening new avenues in epilepsy research, and may one day allow researchers to develop more effective drugs with fewer side effects for the treatment of epileptic seizures.
Full Article